Excess mortalily rates in a cohort of patients infected with the hepatitis C virus: a prospective study

Neal, Keith R.
August 2007
Gut;Aug2007, Vol. 56 Issue 8, p1098
Academic Journal
Objective: We analysed the Trent Hepatitis C cohort to determine standardised mortality ratios in patients infected with hepatitis C virus (HCV), and to identify risk factors and associations with all-cause and liver- related mortality. Design: Cohort study. Setting: Patients with HCV infection attending secondary care within the Trent region of England. Patients: 2285 patients with hepatitis C, followed for 1 year or more. Main outcome measures: The death rate in the cohort was compared to that seen in an age- and sex- matched English population. We performed Cox regression analyses to identify factors predictive of all-cause mortality and deaths from liver disease. Results: Standardised mortality ratios in the cohort were three times higher than those expected in the general population of England. The excess deaths were due to liver-related causes and those associated with a drug- using lifestyle. Significant independent predictors of all-cause mortality were age, sex, treatment (protective) and liver biopsy fibrosis. Age, treatment, liver biopsy fibrosis and mean alcohol consumption were predictors of liver-related mortality. HCV was mentioned on 23% of death certificates overall, and on 52% of those of patients dying from a liver-related cause. Conclusions: Our findings demonstrate that the death rate in patients infected with hepatitis C is three times higher than expected. Severity of disease is associated with a worse prognosis, whilst treatment improves outcome, particularly in those who respond. Use of death certificate data on HCV infection for planning purposes will result in considerable under-estimation of the HCV-related disease burden.


Related Articles

  • Alcoholic Liver Disease-Related Mortality in the United States: 1980—2003. Paula, Helga; Asrani, Sumeet K.; Boetticher, Nicholas C.; Pedersen, Rachel; Shah, Vijay H.; Kim, W. Ray // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1782 

    OBJECTIVES:Data on temporal changes in alcoholic liver disease (ALD)-related mortality in the United States are lacking. This longitudinal assessment is important, given the divergent data on trends in worldwide ALD-related mortality, concerns for underestimation of mortality attributed to ALD...

  • All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population. El-Kamary, Samer S.; Jhaveri, Ravi; Shardell, Michelle D. // Clinical Infectious Diseases;7/15/2011, Vol. 53 Issue 2, p150 

    Background. Liver-related mortality among those infected with hepatitis C virus (HCV) has been described, but little is known about non-liver-related mortality. Our objective was to determine HCV-associated all-cause, liver-, and non-liver-related mortality in the general US population. Methods....

  • Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006–2010. Mahajan, Reena; Xing, Jian; Liu, Stephen J.; Ly, Kathleen N.; Moorman, Anne C.; Rupp, Loralee; Xu, Fujie; Holmberg, Scott D. // Clinical Infectious Diseases;Apr2014, Vol. 58 Issue 8, p1055 

    An observational cohort study using US health system data found that hepatitis C virus (HCV) is underdocumented on death certificates. Only 19% of those with known HCV infection had HCV listed on their death certificate; two-thirds had premortem indications of chronic liver disease.Background....

  • Making the best of a bad situation: early chronic nosocomial HCV infection. Santos, Carmi; Herrine, Steven K. // Digestive Diseases & Sciences;Jun2010, Vol. 55 Issue 6, p1509 

    An introduction to the journal is presented in which the editor discusses a study related to the acute nosocomial hepatitis C virus (HCV) infection and its treatment.

  • HCV, waist circumference linked to greater liver stiffness.  // Infectious Disease News;Oct2013, Vol. 26 Issue 10, p36 

    The article discusses a study published in a 2013 issue of "The Journal of Infectious Diseases" that examined the association between hepatitis C virus (HCV) and liver stiffness.

  • A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Reynolds, W.F.; Patel, K.; Pianko, S.; Blatt, L.M.; Nicholas, J.J.; McHutchison, J.G. // Genes & Immunity;Sep2002, Vol. 3 Issue 6, p345 

    The hepatitis C virus (HCV) is a major cause of fiver disease and the complications of cirrhosis. Liver biopsies, performed prior to the development of liver cirrhosis, characteristically show an inflammatory cell infiltrate with varying degrees of fibrosis. Precisely how HCV infection induces...

  • Hepatology highlights. Méndez-Sánchez, Nahum // Annals of Hepatology: Official Journal of the Mexican Associatio;Nov/Dec2014, Vol. 13 Issue 6, p716 

    The article discusses various reports published within the issue including one on hepatitis C virus (HCV) transmission due to parenteral exposure and another on HCV infection in patients attending two primary care clinics.

  • Liver Disease Is Common in Asymptomatic HCV Infection. Sadovsky, Richard // American Family Physician;4/15/2003, Vol. 67 Issue 8, p1807 

    Discusses the study 'Prevalence of Liver Disease in a Population of Asymptomatic Persons With Hepatitis C Virus Infection,' by A. Alberti et al., from the December 17, 2002 issue of the 'Annals of Internal Medicine.'

  • Introduction.  // Kidney International Supplement;Apr2008, Issue 109, pS6 

    The article discusses various reports published within the issue, including one on Hepatitis C virus infection in the general population and another on liver biopsy in patients with chronic kidney disease.


Read the Article


Sign out of this library

Other Topics